Cas No.: | 89464-63-1 |
Chemical Name: | Dimethyloxalylglycine |
Synonyms: | Glycine,N-(2-methoxy-2-oxoacetyl)-, methyl ester;Dimethyloxaloylglycine;DMOG;Dimethyloxallyl Glycine;Dimethyloxaloylglycine (DMOG);Dimethyloxalylglycine;methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate;N-(2-methoxy-2-oxoacetyl)Glycine methyl ester;N-(Methoxyoxoacetyl)-glycine methyl ester;N-[Methoxy(oxo)acetyl]glycine Methyl Ester;N-[(Methoxycarbonyl)methyl]oxamic acid methyl ester;methyl 2-((2-methoxy-2-oxoethyl)amino)-2-oxoacetate;BNJOZDZCRHCODO-UHFFFAOYSA-N;Glycine, N-(methoxyoxoacetyl)-, methyl ester;METHYL 2-(2-METHOXY-2-OXOETHYLAMINO)-2-OXOACETATE;methyl n-[methoxy(oxo)acetyl]glycinate;dimethyl oxalylglycine;methyl 2-(2-methoxy-2-oxoacetamido)acetate;Dimethy |
SMILES: | O(C([H])([H])[H])C(C([H])([H])N([H])C(C(=O)OC([H])([H])[H])=O)=O |
Formula: | C6H9NO5 |
M.Wt: | 175.1394 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | DMOG (Dimethyloxallyl Glycine) is a cell-permeable and competitive inhibitor of HIF-1α prolyl hydroxylase (HIF-PH). |
In Vivo: | DMOG inhibits endogenous HIF inactivation, and induces angiogenesis in ischaemic skeletal muscles of mice[2]. Up-regulation of hypoxia-inducible factor-1α by DMOG enhances the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats[4]. |
In Vitro: | DMOG efficiently suppresses hydroxyproline synthesis in intact cells, but shows only weakly active in the microsomal system[1]. DMOG reduces FGF-2-induced proliferation and cyclin A expression by inhibiting prolyl hydroxylase activity in HPASMC[3]. |